Anne Strong Caldwell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anne Strong Caldwell has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Anne Lynch
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado
2 shared publicationsEmily McCourt
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado; Department of Ophthalmology, Children's Hospital of Colorado, Aurora, Colorado
2 shared publicationsLauren Mehner
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado; Department of Ophthalmology, Children's Hospital of Colorado, Aurora, Colorado
2 shared publicationsMarc Mathias
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado
2 shared publicationsScott Oliver
Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado
2 shared publicationsZafar S. Gill
2 shared publications
Latest Publications
- 30 April 2026
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 30 (3) , 104847
Comparative outcomes for treatment of type 1 retinopathy of prematurity in a contemporary cohort
- 30 April 2026
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 30 (3) , 104847
Comparative outcomes for treatment of type 1 retinopathy of prematurity in a contemporary cohort
- 22 February 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (4) , 640-646
The Clinical Association of Maternal Asthma and the Development of Retinopathy of Prematurity in Preterm Infants
Purpose: Retinopathy of prematurity (ROP) is a major cause of childhood blindness worldwide. Infant risk factors such as low birth weight, early gestational age, and oxygen exposure are strongly associated with development of ROP. Establishing possible maternal factors, including maternal asthma, may assist in quantifying preterm infants’ risk of developing severe ROP. Methods: A retrospective observational study was performed using the records of the University of Colorado ROP registry from January 2006 to February 2024. Maternal asthma was identified upon review of patients’ clinic notes. Odds ratios (ORs) (with 95% CIs) for ROP risk factors were determined using multinomial logistic regression models, with ROP measures (stage, zone, type, and treatment) as the outcome and history of maternal asthma as the primary explanatory variable. A multivariable analysis was performed to control for birth weight and gestational age. Results: A total of 2237 infants met the inclusion criteria based on birth weight and gestational age, of whom 301 (13.5%) had a mother with a history of asthma. Of these infants, 23 (7.6%) developed type 1 ROP and 28 (9.3%) required treatment. Among infants with maternal asthma history, the adjusted ORs for developing type 1 ROP and type 2 ROP were 2.39 (95% CI, 1.30–4.41; P = .005) and 2.14 (95% CI, 1.25–3.67; P = .006), respectively, and these infants also had 1.87 higher odds (95% CI, 1.13–3.08) of requiring treatment compared with infants who had mothers without asthma ( P = .0145). Conclusions: In this Colorado cohort, maternal asthma was associated with development of treatment-warranted ROP.
- 22 February 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 10 (4) , 640-646
The Clinical Association of Maternal Asthma and the Development of Retinopathy of Prematurity in Preterm Infants
Purpose: Retinopathy of prematurity (ROP) is a major cause of childhood blindness worldwide. Infant risk factors such as low birth weight, early gestational age, and oxygen exposure are strongly associated with development of ROP. Establishing possible maternal factors, including maternal asthma, may assist in quantifying preterm infants’ risk of developing severe ROP. Methods: A retrospective observational study was performed using the records of the University of Colorado ROP registry from January 2006 to February 2024. Maternal asthma was identified upon review of patients’ clinic notes. Odds ratios (ORs) (with 95% CIs) for ROP risk factors were determined using multinomial logistic regression models, with ROP measures (stage, zone, type, and treatment) as the outcome and history of maternal asthma as the primary explanatory variable. A multivariable analysis was performed to control for birth weight and gestational age. Results: A total of 2237 infants met the inclusion criteria based on birth weight and gestational age, of whom 301 (13.5%) had a mother with a history of asthma. Of these infants, 23 (7.6%) developed type 1 ROP and 28 (9.3%) required treatment. Among infants with maternal asthma history, the adjusted ORs for developing type 1 ROP and type 2 ROP were 2.39 (95% CI, 1.30–4.41; P = .005) and 2.14 (95% CI, 1.25–3.67; P = .006), respectively, and these infants also had 1.87 higher odds (95% CI, 1.13–3.08) of requiring treatment compared with infants who had mothers without asthma ( P = .0145). Conclusions: In this Colorado cohort, maternal asthma was associated with development of treatment-warranted ROP.
- 1 November 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (6) , 807-810
MERTK INHIBITOR-ASSOCIATED RETINAL TOXICITY IN A HUMAN
Background/Purpose: The MER proto-oncogene tyrosine kinase (MERTK) helps maintain the homeostasis of the retinal pigmented epithelium. In addition, MERTK regulates the innate immune system. As such, inhibition of MERTK has gained recent interest as a target for cancer therapeutics. Herein, we present MERTK inhibitor-associated retinal toxicity in a human. Methods: A 43-year-old man with medical history of esophageal adenocarcinoma was enrolled in a trial studying the MERTK inhibitor PF-07265807. As part of the study protocol, the patient was seen every 2 to 3 weeks for dilated fundus examinations and ancillary testing. Data on the patient's relevant medical history, ophthalmic examination findings, and imaging performed at baseline and subsequent ophthalmology visits were obtained through retrospective chart review. Results: At the patient's baseline visit, his dilated examination and testing were normal. Seven months after starting the MERTK inhibitor, the patient developed subtle but reproducible signs of retinal toxicity with disruption of the extrafoveal ellipsoid zone on optical coherence tomography and extrafoveal hyperautofluorescence on short wavelength fundus autofluorescence. The patient's vision remained stable throughout the study; however, the medication was stopped because of the unknown ocular effects and progression of the patient's cancer. Conclusion: Patients taking MERTK inhibitors should be monitored by an ophthalmologist while on the drug. If toxicity develops, discussion of whether to continue the medication should take place between the patient, ophthalmologist, and oncologist, with consideration of the risks of vision loss versus benefits of taking the medication from a cancer perspective.
- 1 November 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (6) , 807-810
MERTK INHIBITOR-ASSOCIATED RETINAL TOXICITY IN A HUMAN
Background/Purpose: The MER proto-oncogene tyrosine kinase (MERTK) helps maintain the homeostasis of the retinal pigmented epithelium. In addition, MERTK regulates the innate immune system. As such, inhibition of MERTK has gained recent interest as a target for cancer therapeutics. Herein, we present MERTK inhibitor-associated retinal toxicity in a human. Methods: A 43-year-old man with medical history of esophageal adenocarcinoma was enrolled in a trial studying the MERTK inhibitor PF-07265807. As part of the study protocol, the patient was seen every 2 to 3 weeks for dilated fundus examinations and ancillary testing. Data on the patient's relevant medical history, ophthalmic examination findings, and imaging performed at baseline and subsequent ophthalmology visits were obtained through retrospective chart review. Results: At the patient's baseline visit, his dilated examination and testing were normal. Seven months after starting the MERTK inhibitor, the patient developed subtle but reproducible signs of retinal toxicity with disruption of the extrafoveal ellipsoid zone on optical coherence tomography and extrafoveal hyperautofluorescence on short wavelength fundus autofluorescence. The patient's vision remained stable throughout the study; however, the medication was stopped because of the unknown ocular effects and progression of the patient's cancer. Conclusion: Patients taking MERTK inhibitors should be monitored by an ophthalmologist while on the drug. If toxicity develops, discussion of whether to continue the medication should take place between the patient, ophthalmologist, and oncologist, with consideration of the risks of vision loss versus benefits of taking the medication from a cancer perspective.
- Open Access
Clinical Characteristics, Outcomes, and Cost Associated with Inpatient Intensive Care for Infectious Keratitis
Background and Objectives: Infectious keratitis (IK) is typically managed in an outpatient setting, but patients with severe infections or significant social barriers may require hospital admission. In safety-net hospital systems, these admissions to the intensive care unit (ICU) occur due to hospital protocols for frequent topical antibiotic administration. This study aims to characterize the ocular and social risk factors, visual outcomes, and financial costs associated with ICU admission for IK in an underserved population. Materials and Methods: We conducted a retrospective case series of all patients admitted to the ICU for primary treatment of IK at the Denver Health Medical Center between 1 January 2017 and 31 December 2022. Patients admitted for other medical issues with concurrent IK were excluded. Demographic data, ocular and social risk factors, microbiological culture results, reasons for admission, length of stay, hospital charges, and clinical outcomes were obtained via chart review. Results: Fourteen patients with 16 ICU admissions were included. The average age was 51.7 years, and 79% were male. Most patients endorsed current illicit drug use (71%), and 36% were unhoused. The most common ocular risk factor was trauma (43%). Mean length of stay was 7.43 days, with a mean hospital charge of $48,535.90 per admission. Most ulcers were large (88%) and presented with poor vision (only 19% had better than hand motion vision). The most common reason for ICU admission was concern about outpatient compliance (63%). At last follow-up, 40% of patients had stable vision and 40% had improved vision compared to admission. Conclusions: ICU admission for IK in patients with significant social barriers may preserve vision, but it comes with substantial financial and societal cost. Alternative care strategies and preventative interventions should be considered to reduce reliance on ICU resources while maintaining effective treatment.
Open AccessClinical Characteristics, Outcomes, and Cost Associated with Inpatient Intensive Care for Infectious Keratitis
Background and Objectives: Infectious keratitis (IK) is typically managed in an outpatient setting, but patients with severe infections or significant social barriers may require hospital admission. In safety-net hospital systems, these admissions to the intensive care unit (ICU) occur due to hospital protocols for frequent topical antibiotic administration. This study aims to characterize the ocular and social risk factors, visual outcomes, and financial costs associated with ICU admission for IK in an underserved population. Materials and Methods: We conducted a retrospective case series of all patients admitted to the ICU for primary treatment of IK at the Denver Health Medical Center between 1 January 2017 and 31 December 2022. Patients admitted for other medical issues with concurrent IK were excluded. Demographic data, ocular and social risk factors, microbiological culture results, reasons for admission, length of stay, hospital charges, and clinical outcomes were obtained via chart review. Results: Fourteen patients with 16 ICU admissions were included. The average age was 51.7 years, and 79% were male. Most patients endorsed current illicit drug use (71%), and 36% were unhoused. The most common ocular risk factor was trauma (43%). Mean length of stay was 7.43 days, with a mean hospital charge of $48,535.90 per admission. Most ulcers were large (88%) and presented with poor vision (only 19% had better than hand motion vision). The most common reason for ICU admission was concern about outpatient compliance (63%). At last follow-up, 40% of patients had stable vision and 40% had improved vision compared to admission. Conclusions: ICU admission for IK in patients with significant social barriers may preserve vision, but it comes with substantial financial and societal cost. Alternative care strategies and preventative interventions should be considered to reduce reliance on ICU resources while maintaining effective treatment.
- 7 February 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 29 (2) , 104123
Carotid cavernous fistula complicated by contralateral abducens palsy and optic neuropathy
- 7 February 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 29 (2) , 104123
Carotid cavernous fistula complicated by contralateral abducens palsy and optic neuropathy
- 15 July 2024
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 33 (11) , e89-e91
Occlusion of Xen Gel Stent With Descemet’s Membrane Relieved by Nd:YAG Laser
The Xen gel stent is a minimally invasive glaucoma surgical implant designed to decrease intraocular pressure (IOP) by creating an aqueous outflow path into the subconjunctival space. Since FDA approval, it has demonstrated good safety and efficacy data; however, there are multiple reports of Xen stent occlusions with debris from the anterior chamber. Herein, we report a case of a Descemet’s membrane Xen stent occlusion in a 67-year-old woman with a past medical history of primary open angle glaucoma who underwent Xen stent placement through the ab externo approach. Her Descemet’s membrane occlusion was successfully managed by Nd:YAG laser lysis. Although uncommon, small Descemet’s tears or flaps can occlude the ostia of Xen stents causing elevated IOP or bleb failure. Few reports have described the use of Nd:YAG laser to successfully treat ostium occlusion of any kind with the Xen stent. We discuss the importance of early Nd:YAG laser to relieve Descemet’s membrane occlusions, lower IOP, and rescue the bleb from failure.
- 15 July 2024
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 33 (11) , e89-e91
Occlusion of Xen Gel Stent With Descemet’s Membrane Relieved by Nd:YAG Laser
The Xen gel stent is a minimally invasive glaucoma surgical implant designed to decrease intraocular pressure (IOP) by creating an aqueous outflow path into the subconjunctival space. Since FDA approval, it has demonstrated good safety and efficacy data; however, there are multiple reports of Xen stent occlusions with debris from the anterior chamber. Herein, we report a case of a Descemet’s membrane Xen stent occlusion in a 67-year-old woman with a past medical history of primary open angle glaucoma who underwent Xen stent placement through the ab externo approach. Her Descemet’s membrane occlusion was successfully managed by Nd:YAG laser lysis. Although uncommon, small Descemet’s tears or flaps can occlude the ostia of Xen stents causing elevated IOP or bleb failure. Few reports have described the use of Nd:YAG laser to successfully treat ostium occlusion of any kind with the Xen stent. We discuss the importance of early Nd:YAG laser to relieve Descemet’s membrane occlusions, lower IOP, and rescue the bleb from failure.
- 17 January 2024
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 40 (3) , e82-e83
Congenital Eyelid Imbrication and Floppy Eyelid Syndromes Complicated by Eversion due to Prostaglandin E Infusion in a Patient With Trisomy 21 and Tetralogy of Fallot
Congenital eyelid imbrication syndrome is a rare eyelid finding where a long upper lid overlaps the lower lid when the eyes are closed. To date, congenital eyelid imbrication syndrome has been described in the literature less than 10 times. We present a case of congenital eyelid imbrication syndrome in a patient with trisomy 21 and tetralogy of Fallot on a prostaglandin E infusion to maintain a patent ductus arteriosus prior to definitive heart surgery. While on the infusion, the patient developed peripheral edema and flushing due to vasodilation. This coincided with eyelid swelling, conjunctival chemosis, and eversion of the eyelids. Upon cessation of the prostaglandin E1 infusion, his eyelid eversion resolved.
- 17 January 2024
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 40 (3) , e82-e83
Congenital Eyelid Imbrication and Floppy Eyelid Syndromes Complicated by Eversion due to Prostaglandin E Infusion in a Patient With Trisomy 21 and Tetralogy of Fallot
Congenital eyelid imbrication syndrome is a rare eyelid finding where a long upper lid overlaps the lower lid when the eyes are closed. To date, congenital eyelid imbrication syndrome has been described in the literature less than 10 times. We present a case of congenital eyelid imbrication syndrome in a patient with trisomy 21 and tetralogy of Fallot on a prostaglandin E infusion to maintain a patent ductus arteriosus prior to definitive heart surgery. While on the infusion, the patient developed peripheral edema and flushing due to vasodilation. This coincided with eyelid swelling, conjunctival chemosis, and eversion of the eyelids. Upon cessation of the prostaglandin E1 infusion, his eyelid eversion resolved.
- 1 June 2023
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 49 (6) , 595-601
Comparison of cataract surgery outcomes in English proficient and limited English proficiency patients
Purpose: To determine differences in cataract surgery outcomes between English proficient (EP) and limited English proficiency (LEP) patients. Setting: Sue Anschutz-Rodgers Eye Center, Aurora, Colorado. Design: Retrospective. Methods: Patients who underwent phacoemulsification at the Sue Anschutz-Rogers Eye Center between January 2014 and February 2020 were included. Patients who self-identified as needing or preferring an interpreter in medical encounters were defined as LEP. Differences in surgical characteristics and outcomes including cataract maturity, surgical complexity, and surgical complications were analyzed. Results: 868 eyes (6.4%) were identified from LEP patients. LEP patients were more likely to have mature cataracts (5.1% vs 2.3%, P < .0001). LEP patients' surgeries were more likely to be considered complex (27.8% vs 15.3%, P < .0001) and use higher cumulative dissipated energy (mean of 9.5 [SD = 9.5] vs 7.2 [SD = 7.1], P < .0001). Preoperative visual acuity was worse in LEP patients (logMAR 0.566 [SD = 0.64] vs 0.366 [SD = 0.51], P < .0001) but showed greater improvement after surgery (logMAR 0.366 [SD = 0.54] vs 0.254 [SD = 0.41], P < .0001). There were no significant differences in operative time, intraoperative or postoperative complications. More LEP patients were on steroids 4 weeks postoperatively when compared with EP patients (14.6% vs 10.1%, P < .0002). LEP patients were less likely to undergo subsequent YAG capsulotomy (7.3% vs 12.8%, P < .0001). Conclusions: Disparities in cataract outcomes between EP and LEP patients was demonstrated. Further research into ophthalmic health disparities for LEP patients is needed to understand the root causes and how they can be addressed.
- 1 June 2023
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 49 (6) , 595-601
Comparison of cataract surgery outcomes in English proficient and limited English proficiency patients
Purpose: To determine differences in cataract surgery outcomes between English proficient (EP) and limited English proficiency (LEP) patients. Setting: Sue Anschutz-Rodgers Eye Center, Aurora, Colorado. Design: Retrospective. Methods: Patients who underwent phacoemulsification at the Sue Anschutz-Rogers Eye Center between January 2014 and February 2020 were included. Patients who self-identified as needing or preferring an interpreter in medical encounters were defined as LEP. Differences in surgical characteristics and outcomes including cataract maturity, surgical complexity, and surgical complications were analyzed. Results: 868 eyes (6.4%) were identified from LEP patients. LEP patients were more likely to have mature cataracts (5.1% vs 2.3%, P < .0001). LEP patients' surgeries were more likely to be considered complex (27.8% vs 15.3%, P < .0001) and use higher cumulative dissipated energy (mean of 9.5 [SD = 9.5] vs 7.2 [SD = 7.1], P < .0001). Preoperative visual acuity was worse in LEP patients (logMAR 0.566 [SD = 0.64] vs 0.366 [SD = 0.51], P < .0001) but showed greater improvement after surgery (logMAR 0.366 [SD = 0.54] vs 0.254 [SD = 0.41], P < .0001). There were no significant differences in operative time, intraoperative or postoperative complications. More LEP patients were on steroids 4 weeks postoperatively when compared with EP patients (14.6% vs 10.1%, P < .0002). LEP patients were less likely to undergo subsequent YAG capsulotomy (7.3% vs 12.8%, P < .0001). Conclusions: Disparities in cataract outcomes between EP and LEP patients was demonstrated. Further research into ophthalmic health disparities for LEP patients is needed to understand the root causes and how they can be addressed.
- 10 October 2022
- Published by Elsevier in Ophthalmology
- Vol. 130 (9) , 957
Malignant Idiopathic Intracranial Hypertension
- 10 October 2022
- Published by Elsevier in Ophthalmology
- Vol. 130 (9) , 957
Malignant Idiopathic Intracranial Hypertension
- Open Access
- 1 November 2021
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 15, 4431-4438
Risk of Refractive Prediction Error After Cataract Surgery in Patients with Thyroid Eye Disease
Purpose: To investigate the risk of unexpected refractive prediction error after cataract surgery in patients with thyroid eye disease (TED) at the University of Colorado. Patients and Methods: A retrospective observational study was performed using records of patients who underwent cataract surgery (2014 to 2018) who were included in a Cataract Surgery Outcomes database. Any patient with documentation of thyroid eye disease (TED) in the medical record was classified as TED. Post-operative refraction error greater than or equal to ± 1.0 diopter from the target refraction was the main outcome of this study. Eyes with history of refractive surgery, ocular trauma, retinal detachment, non-Graves’ disease thyroid conditions or Graves’ disease without TED, and eyes without refractive error at follow-up were excluded. Results: A total of 5716 eyes from 3692 patients who underwent cataract surgery were analyzed. Sixty-five eyes of thirty-nine patients (1.1%) had TED. Former and/or current cigarette use was associated with having TED (p = 0.0504). Patients with TED had a statistically significant shorter axial length as compared to eyes without TED (p = 0.0257). Three hundred and forty-nine eyes (6.1%), including 9 eyes (13.8%) in patients with TED, had refractive prediction error greater than ± 1.0 diopter following surgery (univariate OR = 2.5, 95% CI: 1.1– 5.7, p = 0.0274). After multivariate analysis controlling for race, tobacco use, combined surgery, and axial length, TED was associated with an increased risk of our primary outcome, refractive prediction error greater than ± 1.0 diopter (OR = 2.4, 95% CI: 1.0– 5.7, p = 0.0506). Conclusion: Patients with TED are at increased risk for refractive prediction error following cataract surgery. Discussion with patients regarding their risk and possible need for glasses following surgery is important for setting realistic patient expectations.
- 1 November 2021
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 15, 4431-4438
Open AccessRisk of Refractive Prediction Error After Cataract Surgery in Patients with Thyroid Eye Disease
Purpose: To investigate the risk of unexpected refractive prediction error after cataract surgery in patients with thyroid eye disease (TED) at the University of Colorado. Patients and Methods: A retrospective observational study was performed using records of patients who underwent cataract surgery (2014 to 2018) who were included in a Cataract Surgery Outcomes database. Any patient with documentation of thyroid eye disease (TED) in the medical record was classified as TED. Post-operative refraction error greater than or equal to ± 1.0 diopter from the target refraction was the main outcome of this study. Eyes with history of refractive surgery, ocular trauma, retinal detachment, non-Graves’ disease thyroid conditions or Graves’ disease without TED, and eyes without refractive error at follow-up were excluded. Results: A total of 5716 eyes from 3692 patients who underwent cataract surgery were analyzed. Sixty-five eyes of thirty-nine patients (1.1%) had TED. Former and/or current cigarette use was associated with having TED (p = 0.0504). Patients with TED had a statistically significant shorter axial length as compared to eyes without TED (p = 0.0257). Three hundred and forty-nine eyes (6.1%), including 9 eyes (13.8%) in patients with TED, had refractive prediction error greater than ± 1.0 diopter following surgery (univariate OR = 2.5, 95% CI: 1.1– 5.7, p = 0.0274). After multivariate analysis controlling for race, tobacco use, combined surgery, and axial length, TED was associated with an increased risk of our primary outcome, refractive prediction error greater than ± 1.0 diopter (OR = 2.4, 95% CI: 1.0– 5.7, p = 0.0506). Conclusion: Patients with TED are at increased risk for refractive prediction error following cataract surgery. Discussion with patients regarding their risk and possible need for glasses following surgery is important for setting realistic patient expectations.